Eledon Pharmaceuticals replaces auditor KMJ Corbin with Crowe LLP; no disagreements reported

Eledon Pharmaceuticals, Inc.

Audit committee dismissed KMJ Corbin and appointed Crowe LLP on July 10, 2024, after KMJ partners joined Crowe.
KMJ's reports for fiscal years 2022 and 2023 contained no adverse opinion but included a going concern explanatory paragraph.
No disagreements or reportable events occurred during the two most recent fiscal years and subsequent interim period.
KMJ provided a letter agreeing with the company's statements, filed as Exhibit 16.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.